SCHEMBL19828243

SCHEMBL19828243

C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4C2/C3=N/OCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)ON2C(=O)CCC2=O)O1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 10/20 0.56
▸ MAPT P10636 8/20 0.56
▸ SMN1; SMN2 Q16637 7/20 0.56
▸ ALDH1A1 P00352 5/20 0.56
▸ KDM4E B2RXH2 5/20 0.56
▸ CYP2C19 P33261 4/20 0.56
▸ LMNA P02545 4/20 0.56
▸ MAPK1 P28482 4/20 0.56
▸ TDP1 Q9NUW8 4/20 0.56
▸ TP53 P04637 4/20 0.56
▸ USP2 O75604 4/20 0.56
▸ TSHR P16473 3/20 0.56
▸ MT-ND4 P03905 3/20 0.56
▸ CYP2C9 P11712 2/20 0.56
▸ NPC1 O15118 2/20 0.56
▸ RAB9A P51151 2/20 0.56
▸ CYP1A2 P05177 2/20 0.56
▸ HPGD P15428 2/20 0.56
▸ GMNN O75496 1/20 0.56
▸ ABCB11 O95342 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13056398 1.00 CYP3A4 (0.56) CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL13056517 0.95 CYP3A4 (0.49) CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL19828215 0.90 CYP3A4 (0.59) CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL13056397 0.90 CYP3A4 (0.59) CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL13056404 0.89 CYP3A4 (0.58) CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL13082028 0.89 CYP3A4 (0.66) CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL14155415 0.87 CYP3A4 (0.53) CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL13056512 0.85 CYP3A4 (0.52) CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL13056516 0.84 CYP3A4 (0.51) CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL13056513 0.84 CYP3A4 (0.58) CYP3A4MAPTSMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3564674-A1 HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE Ventana Medical Systems, Inc. (US) 2019-11-06 — — EP disclosed
EP-3276349-A1 HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE Ventana Medical Systems, Inc. (US) 2018-01-31 — — EP disclosed
Send feedback